IP STARS
Login
Subscribe
Free Trial
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Events
Conferences
Awards
Webinars
Conferences
Awards
Webinars
Show Search
Submit Search
Search Query
Menu
Submit Search
Search Query
IP Strategy
Copyright
Patents
Trademarks
Topics
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
AI
Automotive
Blockchain and NFTs
Counterfeiting & E-commerce
Designs
Diversity & Inclusion
FRAND & SEPs
IP Offices
Life Sciences
Trade Secrets
Unitary Patent & UPC
Jurisdictions
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Africa
Asia-Pacific
Europe
Latin America and Caribbean
Middle East
North America
Expert Analysis
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Features
Special Focus
Local Insights
PDF Archive
Podcasts
Events
Conferences
Awards
Webinars
Conferences
Awards
Webinars
Login
Subscribe
Free Trial
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility
|
Terms of Use
|
Privacy Policy
|
Modern Slavery Statement
Cookies Settings
Life Sciences IP Focus 8th edition (September 2010)
Main
Editorial
Interview: How to manage an in-house IP team
Understand the economics behind licensing deals
What the EPO’s rule changes mean for life science applicants
Case law clarifies patent questions
Australia ponders the patentability of genes
Are patents for orphan drugs crucial?
Japan moves to protect drug innovators
Mexico gets ready to approve biocomparable drugs
Lessons from the Valcyte patent battle
Tap into Japan’s demand for functional foods
Inaugural revocation proceedings in Singapore
The progression of patentability
Editorial
Features / Articles
Sponsored